Copyright
©The Author(s) 2023.
World J Clin Oncol. Oct 24, 2023; 14(10): 357-372
Published online Oct 24, 2023. doi: 10.5306/wjco.v14.i10.357
Published online Oct 24, 2023. doi: 10.5306/wjco.v14.i10.357
Table 1 Clinical features of Burkitt lymphoma patients
| Clinical features | Total (n = 36) |
| Age, mean (range) | 31.0 (2-90) |
| Gender | |
| Male | 24 |
| Female | 11 |
| Unknown | 1 |
| Stage | |
| I | 4 |
| II | 10 |
| III | 5 |
| IV | 6 |
| Unknown | 11 |
| Survival status | |
| Alive | 20 |
| Dead | 7 |
| Unknown | 9 |
| Ki 67 | |
| ≤ 75% | 4 |
| 75%-90% | 9 |
| > 90% | 22 |
| Unknown | 1 |
| CCS | |
| < 10 | 29 |
| ≥ 10 | 5 |
| Unknown | 4 |
- Citation: Xu YF, Wang GY, Zhang MY, Yang JG. Hub genes and their key effects on prognosis of Burkitt lymphoma. World J Clin Oncol 2023; 14(10): 357-372
- URL: https://www.wjgnet.com/2218-4333/full/v14/i10/357.htm
- DOI: https://dx.doi.org/10.5306/wjco.v14.i10.357